These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 232489
21. Angiotensin I conversion by the microcirculation of the nonhuman primate. Cornish KG, Gilmore JP. Blood Vessels; 1981; 18(3):128-33. PubMed ID: 6261858 [Abstract] [Full Text] [Related]
22. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. Farquharson CA, Struthers AD. J Am Coll Cardiol; 2002 Mar 06; 39(5):767-75. PubMed ID: 11869839 [Abstract] [Full Text] [Related]
23. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats. Sweet CS, Arbegast PT, Gaul SL, Blaine EH, Gross DM. Eur J Pharmacol; 1981 Dec 03; 76(2-3):167-76. PubMed ID: 6174351 [Abstract] [Full Text] [Related]
26. Pressor sensitivity to angiotensin I and angiotensin II during the development of experimental renal hypertension in the rat. Doyle AE, Harrap SB, Torresi J. Clin Exp Pharmacol Physiol; 1986 Jul 03; 13(7):563-8. PubMed ID: 3024889 [Abstract] [Full Text] [Related]
27. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Jorde UP, Vittorio T, Katz SD, Colombo PC, Latif F, Le Jemtel TH. Circulation; 2002 Aug 27; 106(9):1055-7. PubMed ID: 12196328 [Abstract] [Full Text] [Related]
29. Fate of bradykinin-potentiating peptide 9a after intravenous injection. Martin LC, Ryan JW, Fisher GH, Chung A, Epstein M, Stewart JM. Biochem J; 1979 Dec 15; 184(3):713-6. PubMed ID: 540061 [Abstract] [Full Text] [Related]
30. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JM, McMurray JJ. J Am Coll Cardiol; 2001 Mar 15; 37(4):1056-61. PubMed ID: 11263608 [Abstract] [Full Text] [Related]
31. The effects of pathophysiologic state on the metabolism of vasoactive peptides by mammalian lung. Stalcup SA, Leuenberger P, Greenbaum LM, Mellins RB, Turino GM. Bull Eur Physiopathol Respir; 1979 Mar 15; 15(5):1031-44. PubMed ID: 228783 [Abstract] [Full Text] [Related]
32. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats. Vollmer RR, Boccagno JA. Eur J Pharmacol; 1977 Sep 15; 45(2):117-25. PubMed ID: 198216 [Abstract] [Full Text] [Related]
38. Effect of hypoxia on the conversion of angiotensin I to II in the isolated perfused rat lung. Oparil S, Winternitz S, Gould V, Baerwaldt M, Szidon P. Biochem Pharmacol; 1982 Apr 01; 31(7):1375-9. PubMed ID: 7092927 [Abstract] [Full Text] [Related]
39. Relationship between inhibition of pressor response to angiotensin I and blood concentration of captopril following a single oral administration to dogs. Koike H, Ikeda T, Komai T, Kawai K, Miyamota M, Shindo H. Eur J Pharmacol; 1981 Feb 19; 69(4):447-51. PubMed ID: 6265226 [Abstract] [Full Text] [Related]
40. Angiotensin antagonists with increased specificity for the renal vasculature. Taub KJ, Caldicott WJ, Hollenberg NK. J Clin Invest; 1977 Mar 19; 59(3):528-35. PubMed ID: 190270 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]